Navigation Links
Bioponic Phytoceuticals Appoints Renowned Physician Dr. Barbara Nabrit-Stephens to Scientific Advisory Board
Date:4/22/2008

KULA, MAUI, Hawaii, April 22 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. (OTC Bulletin Board: BPYT) ("Bioponic" or "the Company") today announced that Dr. Barbara Anne Nabrit-Stephens, MD, MBA, FAAP has joined the Company's Scientific Advisory Board. Dr. Nabrit-Stephens is a board-certified pediatrician with over 30 years of health care experience. As a scientific advisor, Dr. Nabrit-Stephens will help validate and formulate Bioponic's strategies to market its all-natural therapeutic products, including Curecumin(TM) and Curmisinin(TM).

"We are honored to welcome Dr. Nabrit-Stephens to our Scientific Advisory Board. Dr. Nabrit-Stephens' in-depth experience as both a clinician and health care administrator is a true asset to our organization," said Steven M. Schorr, Chairman and CEO of Bioponic. "Testing and research programs for Alzheimer's applications for Curecumin(TM) and distribution of Curmisinin(TM) to treat the deadly cerebra malaria, which kills over 2 million children in Sub-Saharan Africa, are the first projects Dr. Nabrit-Stephens will be involved in. She is also ideally suited to advise us on our newest product line, Gentle Mother, specifically for the needs of newborns and infants."

Dr. Nabrit-Stephens said, "I've always been attracted to those companies who focus on providing pro-active healthcare solutions, especially to those populations at-risk. Bioponic's work in bringing all-natural treatments to control devastating malaria in Africa is very impressive. I believe Bioponic's Bioresonant formulations could potentially represent a breakthrough in the treatment of epidemic disease. I am intrigued to discover more about the Company and their product lines, and look forward to our ongoing collaboration."

Dr. Nabrit-Stephens earned her medical degree from Tufts University in 1976, her BA from Harvard University in 1972, and her MBA from the University of Tennessee in 1998. She served as a private pediatrician for years in Nashville, Tennessee, before she joined the health-care administration industry in the late 1990s. Dr. Nabrit Stephens is currently Medical Director of Care Management at Blue Cross Blue Shield of Florida in Tampa. Prior to joining BC/BS in 2006, Dr. Nabrit-Stephens was Vice President, Medical Affairs at Keystone Mercy Health, Southeastern Pennsylvania's largest medical assistance managed health care plan organization from 2003 to 2005. Her previous administrative professional positions include Medical Director at OmniCare Health Plan and Plan Medical Director at Tennessee Managed Care Network.

Dr. Nabrit-Stephens also has a wealth of experience in academia. She has served as an assistant professor, director of education for the Department of Pediatrics, Meharry Medical College, and an assistant clinical professor at the Vanderbilt University School of Medicine. In addition, she has done varied research, particularly in the area of HIV/AIDS, where she worked with pregnant women who were HIV-positive and transmitting the virus from mother to baby.

About Bioponic Phytoceuticals

Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic(TM) products. The Company has developed several branded product lines (including the nasal spray: Flight Spray(R) (http://www.flightspray.com) and the skincare product Hawaiian Healing Mist(TM)). Bioponic is focused on the production of natural products that are used to promote health and well-being. Visit http://www.bioponic.com.

All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.

CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, info@bioponic.com or Rick McCaffrey, Investor Relations, OTC Financial Network, 781-444-6100x625, rick@otcfn.com, http://www.otcfn.com/bpyt.


'/>"/>
SOURCE Bioponic Phytoceuticals
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Bioponic Phytoceuticals Announces Curecumin(TM) May Lower Heart Failure Risk
2. Bioponic Phytoceuticals Announces Master Distributorship With Natures Best Covering 1,000 West Coast Retailers
3. Bioponic Phytoceuticals Introduces All Natural Baby Product Suite Gentle Mother
4. Bioponic Phytoceuticals Retains OTC Financial Network for Investor Relations
5. MDS Appoints Two New Directors
6. MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors
7. Bioniche Appoints U.S. President of Food Safety
8. WellPoint Appoints Kevin R. Hayden as President of State Sponsored Business
9. LodgeNet Appoints John E. Haire, Former Time Warner Executive, to Board of Directors
10. ProGenTech Limited Appoints Executive Management Team
11. Precyse Solutions Appoints Karen Heisler as New Corporate Vice President, Human Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology: